ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
A Review of the Great Journey of Capecitabine that Has Been Marketed in China for 20 Years
November 10, 2020Fluorouracil has been used in clinical treatment for more than half a century. Capecitabine, an oral prodrug of fluorouracil, is very convenient to use and is one of the classical chemotherapeutics widely used in clinical practice. -
UK grants marketing authorisation to “landmark” breast cancer therapy
February 23, 2021Seagen’s Tukysa® (tucatinib) was approved in the UK as part of a combination regimen for the treatment of adults with locally advanced or metastatic HER2-positive breast cancer. -
Dr Reddy’s launch Capecitabine Tablets, USP in US
February 18, 2021Capecitabine tablet is indicated for the treatment of Adjuvant Colon Cancer, Metastatic Colorectal Cancer and Metastatic Breast Cancer. -
Seattle Genetics gets approval of TUKYSA in Switzerland for metastatic HER2-positive breast cancer
May 15, 2020Seattle Genetics announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted approval for TUKYSA (tucatinib) tablets in combination with trastuzumab and capecitabine, for the treatment of patients with metastatic HER2-positive breast
Pharma Sources Insight January 2025
